Mechanisms of transcription fidelity in prokaryotes and eukaryotes

原核生物和真核生物转录保真度的机制

基本信息

  • 批准号:
    8763224
  • 负责人:
  • 金额:
    $ 54.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Mechanisms controlling transcription fidelity were addressed by site directed mutagenesis based on the structural data. It has been recently reported that substitutions of His1085 in the Rpb1 subunit of yeast Pol II, which is a part of a mobile element involved in a direct contact with beta and gamma phosphates of the incoming NTP, strongly inhibit incorporation of the matched NTP, but have lesser effect on incorporation of the mismatched and 2-dNTPs. Holmes et al. targeted the Arg678 and Asp814 residues in the beta subunit of EcRNAP that were predicted to be crucial for the coordination of the NTP-associated metal ion in the active site. However, mutation of these residues did not affect transcription. Evidently, the complexity of the Pol II/EcRNAP structure appears to limit the capacity of the structure-driven site-directed mutagenesis for identification of functionally meaningful mutations. Therefore, alternatives to the structure-driven site-directed mutagenesis might be informative.
基于结构数据通过定点诱变解决控制转录保真度的机制。最近有报道称,酵母Pol II的Rpb 1亚基中His 1085的取代强烈抑制了匹配NTP的掺入,但对错配和2-dNTP的掺入影响较小,所述Rpb 1亚基是参与与引入NTP的β和γ磷酸盐直接接触的移动的元件的一部分。Holmes等人靶向了EcRNAP β亚基中的Arg 678和Asp 814残基,这些残基被预测对活性位点中NTP相关金属离子的配位至关重要。然而,这些残基的突变并不影响转录。显然,Pol II/EcRNAP结构的复杂性似乎限制了结构驱动的定点诱变用于鉴定功能上有意义的突变的能力。因此,结构驱动的定点诱变的替代方案可能是有益的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MIKHAIL KASHLEV其他文献

MIKHAIL KASHLEV的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MIKHAIL KASHLEV', 18)}}的其他基金

Transcription Through Nucleosomes by RNA Polymerase II
RNA 聚合酶 II 通过核小体进行转录
  • 批准号:
    6559227
  • 财政年份:
  • 资助金额:
    $ 54.38万
  • 项目类别:
TRANSCRIPTION ELONGATION BY RNA POLYMERASE II
RNA 聚合酶 II 的转录延伸
  • 批准号:
    6419986
  • 财政年份:
  • 资助金额:
    $ 54.38万
  • 项目类别:
Mechanisms of transcription fidelity in prokaryotes and eukaryotes
原核生物和真核生物的转录保真度机制
  • 批准号:
    9153672
  • 财政年份:
  • 资助金额:
    $ 54.38万
  • 项目类别:
Basic Mechanism of Transcription Elongation by E. coli R
大肠杆菌 R 转录延伸的基本机制
  • 批准号:
    6763559
  • 财政年份:
  • 资助金额:
    $ 54.38万
  • 项目类别:
Transcription Through Nucleosomes in Vitro by E. coli RN
大肠杆菌 RN 通过核小体进行体外转录
  • 批准号:
    6951653
  • 财政年份:
  • 资助金额:
    $ 54.38万
  • 项目类别:
Identification of protein factors and pathways leading t
鉴定导致 t 的蛋白质因子和途径
  • 批准号:
    7291718
  • 财政年份:
  • 资助金额:
    $ 54.38万
  • 项目类别:
Monitoring of Basic Biochemical Processes at Single Molecule Level Using Light-e
使用 Light-e 监测单分子水平的基本生化过程
  • 批准号:
    7965613
  • 财政年份:
  • 资助金额:
    $ 54.38万
  • 项目类别:
Mechanisms of transcription fidelity in prokaryotes and eukaryotes
原核生物和真核生物转录保真度的机制
  • 批准号:
    8349168
  • 财政年份:
  • 资助金额:
    $ 54.38万
  • 项目类别:
Mechanism of the initial steps in transcription-coupled DNA repair (TCR)
转录偶联 DNA 修复 (TCR) 初始步骤的机制
  • 批准号:
    8349391
  • 财政年份:
  • 资助金额:
    $ 54.38万
  • 项目类别:
Mechanisms of transcription fidelity in prokaryotes and eukaryotes
原核生物和真核生物转录保真度的机制
  • 批准号:
    8937848
  • 财政年份:
  • 资助金额:
    $ 54.38万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 54.38万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.38万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 54.38万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.38万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 54.38万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 54.38万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.38万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 54.38万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 54.38万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 54.38万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了